Literature DB >> 28158602

Plakoglobin maintains the integrity of vascular endothelial cell junctions and regulates VEGF-induced phosphorylation of VE-cadherin.

Fumitaka Muramatsu1, Hiroyasu Kidoya1, Hisamichi Naito1, Yumiko Hayashi1, Tomohiro Iba1, Nobuyuki Takakura1.   

Abstract

Plakoglobin, also known as γ-catenin, is a close homolog of β-catenin and interacts with shared protein partners. Functions of β-catenin in cell adhesion are well-documented in terms of maintaining endothelial barrier function by interacting with vascular endothelial (VE)-cadherin. Plakoglobin also interacts with VE-cadherin, but its function in cell adhesion is not well understood. Here, we investigated plakoglobin function in vascular endothelial cell (ECs)-cell junction integrity. Knock-down of plakoglobin expression in ECs did not prevent cell proliferation or cell migration, but induced destabilization of the membrane distribution of VE-cadherin and resulted in increased permeability. Plakoglobin contributes to VE-cadherin-dependent adhesion in the steady state, but on stimulation with vascular endothelial growth factor (VEGF), it is essential for inducing sufficient VE-cadherin phosphorylation on VEGF signaling, thereby destabilizing cell-cell junctions. Furthermore, knock-down of plakoglobin expression increased vascular endothelial protein tyrosine phosphatase activity, an endothelial-specific membrane protein associating with VE-cadherin. These results indicate that plakoglobin plays multiple roles in regulation of cell-cell adhesion in a context dependent manner.
© The Authors 2017. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  VE-PTP; VE-cadherin; VEGF; plakoglobin; vascular endothelial cells

Mesh:

Substances:

Year:  2017        PMID: 28158602     DOI: 10.1093/jb/mvx001

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.

Authors:  Katie M Leick; Anthony B Rodriguez; Marit M Melssen; Mouadh Benamar; Robin S Lindsay; Rebeka Eki; Kang-Ping Du; Mahmut Parlak; Tarek Abbas; Victor H Engelhard; Craig L Slingluff
Journal:  Ann Surg       Date:  2019-10       Impact factor: 12.969

2.  Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.

Authors:  Fevzi Ozer; Ecem Onder Tokuc; Merve Gulsen Bal Albayrak; Gurler Akpinar; Murat Kasap; Veysel Levent Karabas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-14       Impact factor: 3.117

3.  Whole-Exome Sequencing of Adult and Pediatric Cohorts of the Rare Vascular Disorder Systemic Capillary Leak Syndrome.

Authors:  Richard Pierce; Weizhen Ji; Eunice C Chan; Zhihui Xie; Lauren M Long; Mustafa Khokha; Saquib Lakhani; Kirk M Druey
Journal:  Shock       Date:  2019-08       Impact factor: 3.454

4.  Scutellaria barbata D. Don Polysaccharides Inhibit High Glucose-Induced Proliferation and Angiogenesis of Retinal Vascular Endothelial Cells.

Authors:  Wenjun Li; Hongxia Xiao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-31       Impact factor: 3.168

5.  LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.

Authors:  Ping Liu; Song-Bai Jia; Jing-Ming Shi; Wen-Jie Li; Luo-Sheng Tang; Xia-Hua Zhu; Ping Tong
Journal:  Biosci Rep       Date:  2019-05-15       Impact factor: 3.840

Review 6.  Autoregulatory "Multitasking" at Endothelial Cell Junctions by Junction-Associated Intermittent Lamellipodia Controls Barrier Properties.

Authors:  Jochen Seebach; Nadine Klusmeier; Hans Schnittler
Journal:  Front Physiol       Date:  2021-01-06       Impact factor: 4.566

Review 7.  Vasculogenic Mimicry: Become an Endothelial Cell "But Not So Much".

Authors:  Mónica Fernández-Cortés; Daniel Delgado-Bellido; F Javier Oliver
Journal:  Front Oncol       Date:  2019-08-22       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.